High-risk biochemical recurrence

Clinical trials for High-risk biochemical recurrence explained in plain language.

Never miss a new study

Get alerted when new High-risk biochemical recurrence trials appear

Sign up with your email to follow new studies for High-risk biochemical recurrence, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New drug shows promise for early prostate cancer return

Disease control Ongoing

This study is testing a new drug called xaluritamig in men whose prostate cancer has returned after initial treatment but has not spread. The main goal is to see if the drug is safe and tolerable. About 50 participants will receive the drug, and researchers will monitor side effe…

Matched conditions: HIGH-RISK BIOCHEMICAL RECURRENCE

Phase 1 • Sponsor: Amgen • Aim: Disease control

Last updated Sep 06, 2026 00:00 UTC

High-risk biochemical recurrence

Get alerted when new High-risk biochemical recurrence trials appear

New drug shows promise for early prostate cancer return